Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
12-441 Mdcc
Los Angeles, CA 90095Phone+1 310-206-3952Fax+1 310-206-0209
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Endocrinology, 1989 - 1992
- Technion-Israel Inst of Technology Faculty of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 1988 - 2025
- PA State Medical License 1992 - 2000
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Constructing an Insulin-Like Growth Factor-based Prediction Model Start of enrollment: 2004 Aug 01
Publications & Presentations
PubMed
- 3 citationsEffect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120.Pei Liang, Susanne M Henning, Tristan Grogan, David Elashoff, Jonathan Said
Prostate Cancer and Prostatic Diseases. 2024-12-01 - 4 citationsHumanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4-induced brain pathology.Brendan Miller, Su-Jeong Kim, Kevin Cao, Hemal H Mehta, Neehar Thumaty
Aging Cell. 2024-07-01 - Mitochondrial-derived microprotein MOTS-c attenuates immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration.Hiroshi Kumagai, Su-Jeong Kim, Brendan Miller, Toshiharu Natsume, Junxiang Wan
American Journal of Physiology. Endocrinology and Metabolism. 2024-03-01
Journal Articles
- Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate CancerWilliam J Aronson, Pinchas Cohen, Journal of the National Cancer Institute
Press Mentions
- Do You Need a Vitamin D Supplement?November 2nd, 2022
- CohBar Completes Last Subject Visit in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and ObesityApril 21st, 2021
- Longevity Biotech’s Mitochondrial Therapy Enters INDMarch 16th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: